Grant: Idea to Innovation
McMaster University
$125,000.00
Laterally-fed membrane chromatography (LFMC) device
EF 2016-17
Résumé
The biopharmaceutical industry has experienced remarkable progress in the upstream production capacity of life-saving recombinant protein drugs, both in terms of reactor volumes and product titers. However, downstream processing, which refers to the purification and formulation of these products have failed to keep up. Resin-based column chromatography is considered the main bottleneck in downstream processing. Membrane chromatography which uses a stack of adsorptive membranes as the separation media is one of the promising alternatives. It is significantly faster, more scalable, and cost-effective. However, currently available commercial membrane chromatography devices offer limited product resolution (i.e. purity) and therefore their application is largely limited to the late-stage polishing steps where impurities such as host cell proteins (HCPs), DNA, and viruses are purified in a flow-through mode. A careful evaluation of these devices clearly shows that they have serious design deficiencies. The laterally-fed membrane chromatography (LFMC) device proposed in this project was designed and developed to address this challenge. Our recently published studies have shown that not only are LFMC devices significantly better than other type of membrane chromatography devices, the separation obtained with these is comparable or even better than that obtained with resin-based columns. These devices therefore represent a win-win situation, i.e. high-productivity with high-resolution. We feel that the LFMC devices will revolutionize separation and purification in the biopharmaceutical industry. Overall, the exploitation of this technology would make the life-saving therapeutic proteins more affordable and will speed up their development timelines.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
500190-2016
Name nom
Ghosh, Raja
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Laterally-fed membrane chromatography (LFMC) device
Keyword
NSERC
Application summary
The biopharmaceutical industry has experienced remarkable progress in the upstream production capacity of life-saving recombinant protein drugs, both in terms of reactor volumes and product titers. However, downstream processing, which refers to the purification and formulation of these products have failed to keep up. Resin-based column chromatography is considered the main bottleneck in downstream processing. Membrane chromatography which uses a stack of adsorptive membranes as the separation media is one of the promising alternatives. It is significantly faster, more scalable, and cost-effective. However, currently available commercial membrane chromatography devices offer limited product resolution (i.e. purity) and therefore their application is largely limited to the late-stage polishing steps where impurities such as host cell proteins (HCPs), DNA, and viruses are purified in a flow-through mode. A careful evaluation of these devices clearly shows that they have serious design deficiencies. The laterally-fed membrane chromatography (LFMC) device proposed in this project was designed and developed to address this challenge. Our recently published studies have shown that not only are LFMC devices significantly better than other type of membrane chromatography devices, the separation obtained with these is comparable or even better than that obtained with resin-based columns. These devices therefore represent a win-win situation, i.e. high-productivity with high-resolution. We feel that the LFMC devices will revolutionize separation and purification in the biopharmaceutical industry. Overall, the exploitation of this technology would make the life-saving therapeutic proteins more affordable and will speed up their development timelines.